U
NRX

UBS’s NEPHROGENEX INC COM NRX Stock Holding History

UBS’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7K Buy
+1,466
New +$6.98K ﹤0.01% 9228
2014
Q2 		– Sell
-236
Closed -$2K – 11162
2014
Q1 		$2K Buy
+236
New +$2.4K ﹤0.01% 10120

Other funds holding NRX

RCP
Rho Capital Partners New York $20.4M AUM
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
FNYS
First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
FWCM
First Western Capital Management Los Angeles, California $4.71M AUM 11.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS's NRX Position: Q3 2014 in Review

UBS opened a new position in NEPHROGENEX INC COM (NRX) in Q3 2014: 1,466 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #9228 among its holdings. This is a return to the name: UBS previously reported a position in NRX as recently as Q1 2014.

UBS first reported a position in NRX in Q1 2014 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold NRX as of Q3 2014.

  • UBS held 1,466 shares of NEPHROGENEX INC COM worth $7K as of Q3 2014.
  • NEPHROGENEX INC COM was a new UBS position in Q3 2014.
  • NEPHROGENEX INC COM made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9228 holding.
  • UBS first reported a position in NEPHROGENEX INC COM in Q1 2014 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.